Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Wortman BG, Creutzberg CL, Putter H. et al; PORTEC Study Group.
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.

Br J Cancer 2018;
119 (09) 1067-1074

Bibliographische Angaben herunterladen

Aufrufen in: